Cargando…
A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer
OBJECTIVE: This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. METHODS AND MATERIALS: Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, v...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047307/ https://www.ncbi.nlm.nih.gov/pubmed/24557438 http://dx.doi.org/10.1097/IGC.0000000000000084 |
_version_ | 1782480390580076544 |
---|---|
author | Jeronimo, Jose Bansil, Pooja Lim, Jeanette Peck, Roger Paul, Proma Amador, Juan Jose Mirembe, Florence Byamugisha, Josaphat Poli, Usha Rani Satyanarayana, Labani Asthana, Smita |
author_facet | Jeronimo, Jose Bansil, Pooja Lim, Jeanette Peck, Roger Paul, Proma Amador, Juan Jose Mirembe, Florence Byamugisha, Josaphat Poli, Usha Rani Satyanarayana, Labani Asthana, Smita |
author_sort | Jeronimo, Jose |
collection | PubMed |
description | OBJECTIVE: This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. METHODS AND MATERIALS: Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, visual inspection with acetic acid (VIA), and Papanicolaou test were evaluated among 16,951 eligible women in India, Nicaragua, and Uganda. Women with positive screening results received colposcopy and histologic follow-up as indicated. The positivity of each screening method was calculated overall, by site, and age. In addition, the clinical performance of each screening test was determined for detection of cervical intraepithelial neoplasia (CIN) grade 2 (CIN2+) and CIN grade 3. RESULTS: Moderate or severe dysplasia or cancer (taken together as CIN2+) was diagnosed in 286 women. The positivity rate ranged between 2.4% to 19.6% for vaginal careHPV, 2.9% to 20.2% for cervical careHPV, 5.5% to 34.4% for VIA, and 2.8% to 51.8% for Papanicolaou test. Cervical careHPV was the most sensitive for CIN2+ (81.5%; 95% confidence interval [CI], 76.5–85.8) and CIN grade 3 (85.3%; 95% CI, 78.6–90.6) at all sites, followed by vaginal careHPV (69.6% and 71.3%, respectively). The sensitivity of VIA ranged from 21.9% to 73.6% and Papanicolaou test from 40.7% to 73.7%. The pooled specificities of cervical careHPV, vaginal careHPV, VIA, and Papanicolaou test were 91.6%, 90.6%, 84.2%, and 87.7%, respectively. CONCLUSIONS: careHPV performed well in large multicountry demonstration studies conducted in resource-limited settings that have not previously been conducted this type of testing; its sensitivity using cervical samples or vaginal self-collected samples was better than VIA or Papanicolaou test. The feasibility of using careHPV in self-collected vaginal samples opens the possibility of increasing coverage and early detection in resource-constrained areas. |
format | Online Article Text |
id | pubmed-4047307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-40473072014-06-06 A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer Jeronimo, Jose Bansil, Pooja Lim, Jeanette Peck, Roger Paul, Proma Amador, Juan Jose Mirembe, Florence Byamugisha, Josaphat Poli, Usha Rani Satyanarayana, Labani Asthana, Smita Int J Gynecol Cancer Cervical Cancer OBJECTIVE: This study evaluates the feasibility and performance of careHPV, a novel human papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low-resource settings. METHODS AND MATERIALS: Clinician-collected (cervical) and self-collected (vaginal) careHPV specimens, visual inspection with acetic acid (VIA), and Papanicolaou test were evaluated among 16,951 eligible women in India, Nicaragua, and Uganda. Women with positive screening results received colposcopy and histologic follow-up as indicated. The positivity of each screening method was calculated overall, by site, and age. In addition, the clinical performance of each screening test was determined for detection of cervical intraepithelial neoplasia (CIN) grade 2 (CIN2+) and CIN grade 3. RESULTS: Moderate or severe dysplasia or cancer (taken together as CIN2+) was diagnosed in 286 women. The positivity rate ranged between 2.4% to 19.6% for vaginal careHPV, 2.9% to 20.2% for cervical careHPV, 5.5% to 34.4% for VIA, and 2.8% to 51.8% for Papanicolaou test. Cervical careHPV was the most sensitive for CIN2+ (81.5%; 95% confidence interval [CI], 76.5–85.8) and CIN grade 3 (85.3%; 95% CI, 78.6–90.6) at all sites, followed by vaginal careHPV (69.6% and 71.3%, respectively). The sensitivity of VIA ranged from 21.9% to 73.6% and Papanicolaou test from 40.7% to 73.7%. The pooled specificities of cervical careHPV, vaginal careHPV, VIA, and Papanicolaou test were 91.6%, 90.6%, 84.2%, and 87.7%, respectively. CONCLUSIONS: careHPV performed well in large multicountry demonstration studies conducted in resource-limited settings that have not previously been conducted this type of testing; its sensitivity using cervical samples or vaginal self-collected samples was better than VIA or Papanicolaou test. The feasibility of using careHPV in self-collected vaginal samples opens the possibility of increasing coverage and early detection in resource-constrained areas. Lippincott Williams & Wilkins 2014-03 2014-03-03 /pmc/articles/PMC4047307/ /pubmed/24557438 http://dx.doi.org/10.1097/IGC.0000000000000084 Text en Copyright © 2014 by IGCS and ESGO http://creativecommons.org/licenses/by-nc-nd/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Cervical Cancer Jeronimo, Jose Bansil, Pooja Lim, Jeanette Peck, Roger Paul, Proma Amador, Juan Jose Mirembe, Florence Byamugisha, Josaphat Poli, Usha Rani Satyanarayana, Labani Asthana, Smita A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer |
title | A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer |
title_full | A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer |
title_fullStr | A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer |
title_full_unstemmed | A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer |
title_short | A Multicountry Evaluation of careHPV Testing, Visual Inspection With Acetic Acid, and Papanicolaou Testing for the Detection of Cervical Cancer |
title_sort | multicountry evaluation of carehpv testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer |
topic | Cervical Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047307/ https://www.ncbi.nlm.nih.gov/pubmed/24557438 http://dx.doi.org/10.1097/IGC.0000000000000084 |
work_keys_str_mv | AT jeronimojose amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT bansilpooja amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT limjeanette amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT peckroger amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT paulproma amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT amadorjuanjose amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT mirembeflorence amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT byamugishajosaphat amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT poliusharani amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT satyanarayanalabani amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT asthanasmita amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT amulticountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT jeronimojose multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT bansilpooja multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT limjeanette multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT peckroger multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT paulproma multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT amadorjuanjose multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT mirembeflorence multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT byamugishajosaphat multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT poliusharani multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT satyanarayanalabani multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT asthanasmita multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer AT multicountryevaluationofcarehpvtestingvisualinspectionwithaceticacidandpapanicolaoutestingforthedetectionofcervicalcancer |